Literature DB >> 30022365

Novel frontiers in detecting cancer metastasis.

Stanley P Leong1, Carmen Ballesteros-Merino2, Shawn M Jensen2, Sebastian Marwitz2, Carlo Bifulco3,4, Bernard A Fox2,5, Mojca Skoberne6.   

Abstract

Cancer microenvironment is the critical battle ground between the cancer cells and host response. Thus, more emphasis is directed to study the relationship between cancer cells and the stromal cells. Multiplex microscopy is an emerging technique in which multiple cell populations within the cancer microenvironment may be stained so that spatial relationship between cancer cells and, in particular, the immune cells may be studied during different stages of cancer development. Recent discovery of mutational burden and neoantigens in cancer has opened new landscapes in the interaction of host immune cells and cancer neoantigens. The emerging role of miRNAs may become an added dimension to study cancer beyond traditional pathway of DNA directed RNA being associated with the malignant behavior of cancer. Circulating tumor cells, cancer markers and ctDNA can be used as markers for circulating cancer cells in the blood. Further studies are needed to validate if liquid biopsy of cancer may become a routine clinical tool to screen cancer or follow patients for recurrence or responses to treatment.

Entities:  

Keywords:  Cancer microenvironment; Cancer neoantigens; Circulating tumor cells; Immune cells; MicroRNA

Mesh:

Substances:

Year:  2018        PMID: 30022365     DOI: 10.1007/s10585-018-9918-6

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  53 in total

1.  Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.

Authors:  Nadeem Riaz; Jonathan J Havel; Vladimir Makarov; Alexis Desrichard; Walter J Urba; Jennifer S Sims; F Stephen Hodi; Salvador Martín-Algarra; Rajarsi Mandal; William H Sharfman; Shailender Bhatia; Wen-Jen Hwu; Thomas F Gajewski; Craig L Slingluff; Diego Chowell; Sviatoslav M Kendall; Han Chang; Rachna Shah; Fengshen Kuo; Luc G T Morris; John-William Sidhom; Jonathan P Schneck; Christine E Horak; Nils Weinhold; Timothy A Chan
Journal:  Cell       Date:  2017-10-12       Impact factor: 41.582

2.  Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.

Authors:  Kazuo Koyanagi; Steven J O'Day; Peter Boasberg; Michael B Atkins; He-Jing Wang; Rene Gonzalez; Karl Lewis; John A Thompson; Clay M Anderson; Jose Lutzky; Thomas T Amatruda; Evan Hersh; Jon Richards; Jeffrey S Weber; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

3.  Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.

Authors:  James N Kochenderfer; Robert P T Somerville; Tangying Lu; Victoria Shi; Adrian Bot; John Rossi; Allen Xue; Stephanie L Goff; James C Yang; Richard M Sherry; Christopher A Klebanoff; Udai S Kammula; Marika Sherman; Arianne Perez; Constance M Yuan; Tatyana Feldman; Jonathan W Friedberg; Mark J Roschewski; Steven A Feldman; Lori McIntyre; Mary Ann Toomey; Steven A Rosenberg
Journal:  J Clin Oncol       Date:  2017-03-14       Impact factor: 44.544

Review 4.  Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Authors:  Jason D Merker; Geoffrey R Oxnard; Carolyn Compton; Maximilian Diehn; Patricia Hurley; Alexander J Lazar; Neal Lindeman; Christina M Lockwood; Alex J Rai; Richard L Schilsky; Apostolia M Tsimberidou; Patricia Vasalos; Brooke L Billman; Thomas K Oliver; Suanna S Bruinooge; Daniel F Hayes; Nicholas C Turner
Journal:  J Clin Oncol       Date:  2018-03-05       Impact factor: 44.544

5.  An immunogenic personal neoantigen vaccine for patients with melanoma.

Authors:  Patrick A Ott; Zhuting Hu; Derin B Keskin; Sachet A Shukla; Jing Sun; David J Bozym; Wandi Zhang; Adrienne Luoma; Anita Giobbie-Hurder; Lauren Peter; Christina Chen; Oriol Olive; Todd A Carter; Shuqiang Li; David J Lieb; Thomas Eisenhaure; Evisa Gjini; Jonathan Stevens; William J Lane; Indu Javeri; Kaliappanadar Nellaiappan; Andres M Salazar; Heather Daley; Michael Seaman; Elizabeth I Buchbinder; Charles H Yoon; Maegan Harden; Niall Lennon; Stacey Gabriel; Scott J Rodig; Dan H Barouch; Jon C Aster; Gad Getz; Kai Wucherpfennig; Donna Neuberg; Jerome Ritz; Eric S Lander; Edward F Fritsch; Nir Hacohen; Catherine J Wu
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

6.  MicroRNA (miRNA) in cancer.

Authors:  Kaladhar B Reddy
Journal:  Cancer Cell Int       Date:  2015-04-02       Impact factor: 5.722

7.  Circulating protein and antibody biomarker for personalized cancer immunotherapy.

Authors:  Jianda Yuan
Journal:  J Immunother Cancer       Date:  2016-08-16       Impact factor: 13.751

8.  Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.

Authors:  Victorine A Mensah; Aly Gueye; Magatte Ndiaye; Nick J Edwards; Danny Wright; Nicholas A Anagnostou; Massamba Syll; Amy Ndaw; Annie Abiola; Carly Bliss; Jules-François Gomis; Ines Petersen; Caroline Ogwang; Tandakha Dieye; Nicola K Viebig; Alison M Lawrie; Rachel Roberts; Alfredo Nicosia; Babacar Faye; Oumar Gaye; Odile Leroy; Egeruan B Imoukhuede; Katie J Ewer; Philip Bejon; Adrian V S Hill; Badara Cisse
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

9.  Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors:  Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 10.  Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine.

Authors:  David B Page; Tyler W Hulett; Traci L Hilton; Hong-Ming Hu; Walter J Urba; Bernard A Fox
Journal:  J Immunother Cancer       Date:  2016-05-17       Impact factor: 13.751

View more
  4 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Future perspectives: cancer metastases.

Authors:  Stanley P Leong; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2018-07-23       Impact factor: 5.150

3.  Introduction: Novel Frontiers in Cancer Metastasis.

Authors:  Stanley P Leong; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2022-02-22       Impact factor: 5.150

Review 4.  Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers.

Authors:  Diego Fernández-Lázaro; Juan Luis García Hernández; Alberto Caballero García; Alfredo Córdova Martínez; Juan Mielgo-Ayuso; Juan Jesús Cruz-Hernández
Journal:  Diagnostics (Basel)       Date:  2020-04-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.